logo
episode-header-image
Aug 2024
21m 14s

Renal Cell Carcinoma

JAMA NETWORK
About this episode

Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. Simel, MD, MHS, to discuss the epidemiology, clinical presentation, pathophysiology, and management of renal cell carcinoma.

Related Content:

Up next
May 11
An Overview of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deput ... Show More
17m 34s
May 4
Hepatitis B: Global Insights on Transmission and Treatment
Hepatitis B virus (HBV) infection affects around 254 million people worldwide and causes more than 1 million deaths annually. Author Anna Lok, MD, from the University of Michigan discusses HBV transmission, screening, and treatment with JAMA Associate Editor Beverly Forsyth, MD. ... Show More
21m 34s
Apr 27
Review of Cardiac Resynchronization Therapy
Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac ... Show More
19m 57s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Sep 2025
Urinary Tract Malignancies
Send us Fan MailNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob dive into the essential clinical and pathophysiologic features of urinary tract malignancies, beginning with renal cell carcinoma (RCC) and followed by urothelial carcinoma of the bladder.We start ... Show More
29m 41s
Nov 2023
S2 Episode 6: Rare Disease: Is It Membranous Nephropathy?
Join experts Drs Matthew Sparks and Laurence Beck as they discuss the diagnosis and management of membranous nephropathy, a rare kidney disease. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991606). The topics and ... Show More
29m 23s
Oct 2023
S2 Episode 5: When Is It Time to Talk About Kidney Transplantation?
Join experts Drs Matthew Sparks and Samira Farouk as they pull back the curtain to help patients and providers better understand the transplant journey. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991605). The to ... Show More
28m 50s
Apr 2025
Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More
12m 19s
Mar 2025
Surgical Oncology, Part 2
In the second episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is once again joined by Drs. John Stewart and Prakash Pendalai to discuss the important features of head and neck malignancies, benign and malignant gynecologic conditions, and principles ... Show More
19 m
Nov 2024
Surgical Oncology, Part 1
In this first episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is joined by Drs. John Stewart and Prakash Pendalai to discuss the genetic and molecular features of cancer. They also discuss screening methods and other preventive interventions, with a ... Show More
28m 14s
Jul 2025
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More
17m 45s
Jul 2025
Clinical Challenges in Colorectal Surgery: Early Onset Colorectal Cancer
The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide ... Show More
38m 35s
Jun 2022
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
<p>Patients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease.</p> <p>However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of international collaborators explored ... Show More
11m 24s
Listen to millions of songs and podcasts on Anghami